Feed IQV
IQ

IQVIA

IQV · NYSE

$270.68 +0.37% (+$1.01)
1M +11.78%
Market Cap $44.4B
P/E Ratio 32.26x
Div. Yield -
ROE 21.95%

Bulios Fair Price

$205.5

24.1% downside

Trenutna cena

$270.68

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica IQV trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Odkleni pošteno ceno

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
7/9
Valuation
46 /100
Fair
P/E 32.26x
P/B 7.19x
EV/EBITDA 16.64x
Growth
53 /100
Stable
EPS growth 11.08%
Book val. growth 4.10%
Rev. growth 4.21%
Profitability
64 /100
Moderate
Gross margin 26.23%
FCF margin 15.39%
Net margin 8.10%
Quality
63 /100
Average
ROIC 8.32%
Asset turnover 0.57x
ROE 21.95%
Debt
19 /100
High
Debt/Equity 2.63x
Net debt/EBITDA 4.06x
Current ratio 0.71x
Stability
91 /100
Stable
Beta 1.19x
Profitable years 6
Rev. volatility 1.55%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o IQV
Online

O podjetju

IQVIA Holdings Inc. is a global company specializing in providing a broad range of healthcare information and analytical services. The company is headquartered in Durham, North Carolina. IQVIA operates in the bio-pharmaceutical and healthcare research sector, offering information and tools for pharmaceutical companies, biotechnology firms, healthcare organizations, and other entities.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Ari Bousbib

Employees

94,000

Headquarters

Durham

Prihajajoči dogodki

03 NOV.

Earnings

Upcoming earnings report

48d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.